Easier diabetes management with life-changing results1-5
Patti LaBelle, Dexcom user
Paid spokesperson of Dexcom, Inc.
Paid spokesperson of Dexcom, Inc.
Smart device sold separately.*
Medicare patients on all types of insulin are now covered for Dexcom G7.
Dexcom G7 makes it easier to achieve lasting results5-9—and no other CGM system is more affordable.†
New! Expanded Medicare coverage
Due to recent Medicare changes, millions more people are now covered for Dexcom continuous glucose monitoring (CGM). Dexcom G7 is the smallest, most accurate CGM system10 covered by Medicare‡—and it’s easy to use and get started!11
No other CGM system is more affordable than Dexcom G7 for Medicare patients.†
Learn more and get a free benefits check to see if you qualify. Even if you don’t have CGM coverage, you can take advantage of our pharmacy savings program.
Use overpatch as instructed.
“Dexcom CGM removes the mystery from diabetes. It empowers people living with diabetes to make more informed decisions for themselves.”
Dr. Aaron King
Paid spokesperson of Dexcom, Inc.
Paid spokesperson of Dexcom, Inc.
Easier diabetes management without fingersticks§
Dexcom G7 is a real-time CGM system that sends glucose numbers to your Dexcom receiver and smartphone* without fingersticks.§ An arrow shows the direction your glucose is heading—up, down, or steady—so you can make better decisions about food, insulin, and activity in the moment. Spend more time enjoying your life without the interruption of diabetes.
§If your glucose alerts and readings from the Dexcom CGM do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
Smart device sold separately.*
Smart device sold separately.*
Small wearable
Dexcom G7 is the smallest CGM covered by Medicare.*
Easy to use7-8
Dexcom CGM is easy to apply, easy to wear, and easy to use.7-8 See your glucose numbers in real time by simply glancing at your Dexcom receiver or smartphone.‡
Use overpatch as instructed.
Lower A1C1-5
Using a Dexcom CGM System is proven to lower A1C and help you spend more time in range,1-5 so you can do more of what you love.
Dexcom CGM Systems are covered by Medicare
Dexcom CGM Systems are covered by Medicare for people who meet the coverage criteria.‡
With new expanded coverage, Medicare now covers Dexcom CGM for people with diabetes who are on any type of insulin. Even those who are not on insulin, but experience low blood glucose events, can qualify for Dexcom CGM coverage.
If you’re not on Medicare, you can still fill out the form below to get started.
“Getting Dexcom CGM has truly been life-changing for my mom. I can follow her numbers|| and help prevent the low 30s and 40s she was having. It is also easy enough to use that I can walk her through the setup process over the phone, which is useful since she is elderly with some memory issues.”
– Suzy M.
Get started with Dexcom G7
If you are a new Dexcom user, fill out the Get Started form to get a free benefits check.
If you are a current Dexcom G6 user not on a connected insulin pump, please speak to your doctor about getting a prescription for Dexcom G7. Check out the FAQs for further details.
Are you on a connected pump?
We recommend new users on automated insulin delivery (AID) systems to explore the benefits of Dexcom G6 and for existing users on AID to stay on Dexcom G6 until Dexcom G7 is compatible with your pump.
New Patients: Get Started with Dexcom CGM
Please fill out the form below to help us determine if the Dexcom CGM System is right for you or your loved one. A customer service representative of Dexcom, or a service provider on behalf of Dexcom, may follow up with you to process a full insurance benefits check or to discuss other Dexcom products, services or programs, after reviewing your information.
Personal & Diabetes Information
All fields marked with an asterisk (*) are required.
Have Questions?
If you are a Medicare beneficiary, you may be eligible for CGM coverage if you meet the following criteria:
1. You have been diagnosed with diabetes
2. Your provider has determined that you or their caregiver understands how to use CGM, and you have provided a prescription
3. The CGM is prescribed in accordance with an FDA indication for its use
4. You have been diagnosed with diabetes and meets one of the following criteria:
- You are treated with any insulin, or
- You have a history of problematic hypoglycemia, with documentation of at least of one following:
- One or more Level 2 hypoglycemic events (glucose <54mg/dL) that persist despite one or more modifications of the diabetes treatmentplan and/or adjustment of medication, OR
- One Level 3 hypoglycemic event (glucose <54mg/dL) characterized by altered mental and/or physical state requiring third-party assistance for treatment of hypoglycemia
5. You have an in-person or Medicare-approved visit with the practitioner prescribing the CGM within 6 months of initiating CGM therapy
6. You have an in-person or Medicare-approved visit with the practitioner who prescribed the CGM every 6 months after initiating CGM therapy
Our experts are here to help.
§Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings. *Receiver is required to be used along with smart device in order to receive Medicare benefits for CGM. Compatible smart devices sold separately. To view a list of compatible smart devices, visit dexcom.com/compatibility. †Must meet eligibility requirements. Under Medicare’s DME fee schedule, reimbursement and coinsurance for CGMs using CPT codes A4239 and E2103 are the same, regardless of CGM brand. ‡Medicare covers Dexcom CGM for patients who meet the Medicare coverage criteria. For a list of Medicare coverage criteria, please visit the Center for Medicare and Medicaid services website. ||Separate Follow app and internet connection required. Users should always confirm readings on the Dexcom G6 and Dexcom G7 app or receiver before making treatment decisions.
1 Beck RW, et al. JAMA. 2017;317(4):371-378. 2 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374. 3 Martens T, et al. JAMA. 2021;325(22):2262-2272. 4 Gilbert TR, et al. Diabetes Technol Ther. 2021;23(S1):S35-S39. 5 Welsh JB, et al. J Diabetes Sci Technol. 2022:19322968221099879. 6 Lind M, et al. Diabetes Care. 2021;44(1):141-149. 7 Aleppo G, et al. Diabetes Care. 2021;44(12):2729-2737. 8 Miller KM, et al. Diabetes Technol Ther. 2022;24(6):424-434. 9 Visser MM, et al. The Lancet Diabetes & Endocrinology. 2023;11(2):96-108. 10 Dexcom, data on file, 2022. 11 Dexcom G7 CGM System User Guide. 12 Dexcom G6 CGM System User Guide.
BRIEF SAFETY STATEMENT: Failure to use the Dexcom Continuous Glucose Monitoring System and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the Dexcom CGM do not match symptoms, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency.